Cargando…

HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors with a dismal prognosis and no effective conservative therapeutic strategies. Although it is demonstrated that histone deacetylases (HDACs), especially the class I HDACs HDAC1, 2 and 3 are highly expressed in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schüler, Susanne, Fritsche, Petra, Diersch, Sandra, Arlt, Alexander, Schmid, Roland M, Saur, Dieter, Schneider, Günter
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867820/ https://www.ncbi.nlm.nih.gov/pubmed/20398369 http://dx.doi.org/10.1186/1476-4598-9-80

Ejemplares similares

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells
por: Diersch, Sandra, et al.
Publicado: (2015)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

HDAC2 Facilitates Pancreatic Cancer Metastasis
por: Krauß, Lukas, et al.
Publicado: (2022)

AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
por: Schneeweis, Christian, et al.
Publicado: (2022)

TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
por: Geismann, Claudia, et al.
Publicado: (2018)

NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023)

Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models
por: Diersch, Sandra, et al.
Publicado: (2013)

MTOR inhibitor-based combination therapies for pancreatic cancer
por: Hassan, Zonera, et al.
Publicado: (2018)

LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer
por: Beyer, Katharina, et al.
Publicado: (2017)

Rationale for MYC imaging and targeting in pancreatic cancer
por: Schneider, Günter, et al.
Publicado: (2021)

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
por: Falcomatà, Chiara, et al.
Publicado: (2023)

TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
por: Staniek, Julian, et al.
Publicado: (2019)

Genetic alterations in pancreatic carcinoma
por: Schneider, Gunter, et al.
Publicado: (2003)

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
por: Lane, Denis, et al.
Publicado: (2012)

Quo vadis, Kras?
por: Schneider, Günter, et al.
Publicado: (2013)

Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer
por: Wang, Wei, et al.
Publicado: (2013)

Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
por: Ko, Hyeonseok, et al.
Publicado: (2015)

N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
por: Estornes, Yann, et al.
Publicado: (2018)

c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
por: Geismann, C, et al.
Publicado: (2014)

The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells
por: Zhang, Min, et al.
Publicado: (2015)

HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells
por: Lee, Bok-Soon, et al.
Publicado: (2018)

Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis
por: Stolpmann, K, et al.
Publicado: (2012)

MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
por: Matte, Isabelle, et al.
Publicado: (2014)

TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment
por: Manouchehri, Jasmine M, et al.
Publicado: (2018)

The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer
por: Pimentel, Julio M., et al.
Publicado: (2023)

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis
por: Marini, Patrizia, et al.
Publicado: (2005)

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
por: Mamaghani, Shadi, et al.
Publicado: (2012)

TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
por: Dufour, Florent, et al.
Publicado: (2016)

NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019)

Downregulation of X-linked inhibitor of apoptosis protein by ‘7-Benzylidenenaltrexone maleate’ sensitizes pancreatic cancer cells to TRAIL-induced apoptosis
por: Kim, So Young, et al.
Publicado: (2017)

HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis
por: Ji, Ting, et al.
Publicado: (2020)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
por: Hölscher, Alexander S., et al.
Publicado: (2018)

Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
por: Voss, Oliver H., et al.
Publicado: (2021)

TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
por: Yang, Xi, et al.
Publicado: (2017)

MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
por: Wirth, Matthias, et al.
Publicado: (2014)

Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
por: Lankes, Katharina, et al.
Publicado: (2020)

Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
por: Shen, Xiao, et al.
Publicado: (2023)

TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
por: Krieg, A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_1memlf318htilq2pmkid6mhkp5